OR WAIT null SECS
© 2022 MJH Life Sciences and Optometry Times. All rights reserved.
© 2022 MJH Life Sciences™ and Optometry Times. All rights reserved.
Founder and CEO TearRestore, Inc.
Study: Neurolenses significantly impact reading speed
FDA approves biosimilar product ranibizumab-eqrn for retinal diseases
Aerie doses first patient in COMET-3 study for DED treatment
EyeCare4Kids names new executive director